Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMMU

Immunomedics (IMMU) Stock Price, News & Analysis

Immunomedics logo

About Immunomedics Stock (NASDAQ:IMMU)

Advanced Chart

Key Stats

Today's Range
$87.86
$87.86
50-Day Range
$85.08
$87.86
52-Week Range
$8.80
$87.93
Volume
N/A
Average Volume
4.01 million shs
Market Capitalization
$20.31 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMMU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immunomedics and its competitors with MarketBeat's FREE daily newsletter.

IMMU Stock News Headlines

Gilead Sciences Tops Estimates in Q3
F1 Engineering Powers This Electric Marine Motor
The future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLaren Engineering, a NASDAQ-listed marine tech company unveiled a groundbreaking new electric powertrain set to transform the industry.
Gilead Sciences Shows Strong Q3 Results Amid Strategic Initiatives
See More Headlines

IMMU Stock Analysis - Frequently Asked Questions

Immunomedics, Inc. (NASDAQ:IMMU) announced its quarterly earnings results on Wednesday, August, 5th. The biopharmaceutical company reported ($0.73) earnings per share for the quarter, missing the consensus estimate of ($0.34) by $0.39. The biopharmaceutical company had revenue of $20.07 million for the quarter, compared to the consensus estimate of $24.81 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Immunomedics investors own include Bristol Myers Squibb (BMY), NVIDIA (NVDA), Seagen (SGEN), Synergy Pharmaceuticals (SGYP), Micron Technology (MU), Gilead Sciences (GILD) and Meta Platforms (META).

Company Calendar

Last Earnings
8/05/2020
Today
7/08/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:IMMU
Fax
N/A
Employees
366
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$357.19 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$290 thousand
Price / Sales
70,028.66
Price / Cash Flow
N/A
Book Value
$1.38 per share
Price / Book
63.67

Miscellaneous

Free Float
N/A
Market Cap
$20.31 billion
Optionable
Optionable
Beta
2.90
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:IMMU) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners